Cytidine 5'-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model

Pediatric Research

Volumn 74, Issue 1, 2013, Pages 26-33

  Cetinkaya, Merih ^a   Cansev, Mehmet ^b   Kafa, Ilker M ^b   Tayman, Cuneyt ^a   Cekmez, Ferhat ^a   Canpolat, Fuat Emre ^a   Tunc, Turan ^a   Sarici, S Umit ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CITICOLINE; CYTOKINE; DNA NUCLEOTIDYLEXOTRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEMBRANE PROTEIN; PHOSPHOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; HISTOPATHOLOGY; HYPEROXIA; LAMELLAR BODY; LIPID PEROXIDATION; LUNG FIBROSIS; LUNG FLUID; LUNG HOMOGENATE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; CYTIDINE DIPHOSPHATE CHOLINE; DISEASE MODELS, ANIMAL; HYPEROXIA; LUNG INJURY; RATS;

EID: 84880291831     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.68     Document Type: Article

References (40)

1. Thomas W, Speer CP. Prevention and treatment of bronchopulmonary dysplasia: current status and future prospects. J Perinatol 2007;27: S26-32.
2. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23: 305-13.
3. Laughon MM, Smith PB, Bose C. Prevention of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009;14: 374-82.
4. Adibhatla RM, Hatcher JF. Cytidine 5'-diphosphocholine (CDPcholine) in stroke and other CNS disorders. Neurochem Res 2005;30: 15-23.
5. Zimmermann LJ, Janssen DJ, Tibboel D, Hamvas A, Carnielli VP. Surfactant metabolism in the neonate. Biol Neonate 2005;87: 296-307.
6. Merrill JD, Ballard RA, Cnaan A, et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004;56: 918- 26.
7. Laughon M, Bose C, Moya F, et al.; Surfaxin Study Group. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia. Pediatrics 2009;123: 89-96.
8. Colombo ML, Dogliani P, Raggi M. [Relation between citicoline and pulmonary surfactant. Recent acquisitions in the treatment of respiratory syndromes of the newborn]. Minerva Pediatr 1976;28: 2303-10.
9. Valls i Soler A, Sanjurjo P, Vazquez Cordero C. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome]. An Esp Pediatr 1988;28: 493-6.
10. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53: 81-94.
11. Warner BB, Stuart LA, Papes RA, Wispe Jr. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998;275(1 Pt 1): L110-7.
12. Mantell LL, Horowitz S, Davis JM, Kazzaz JA. Hyperoxia-induced cell death in the lung - the correlation of apoptosis, necrosis, and inflammation. Ann NY Acad Sci 1999;887: 171-80.
13. McGrath-Morrow SA, Stahl J. Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 2001;25: 150-5.
14. Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004;55: 1009-17.
15. Paananen R, Husa AK, Vuolteenaho R, Herva R, Kaukola T, Hallman M. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009;154: 39-43.e3.
16. Cansev M, Yilmaz MS, Ilcol YO, Hamurtekin E, Ulus IH. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol 2007;577: 129-42.
17. Wurtman RJ, Cansev M, Ulus IH. Choline and its products acetylcholine and phosphatidylcholine. In: Lajtha A, ed. Neural Lipids, Handbook of Neurochemistry and Molecular Neurobiology. Berlin, Heidelberg: Springer-Verlag, 2009: 443-501.
18. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 2008;14: 567-74.
19. Ilcol YO, Yilmaz Z, Ulus IH. Endotoxin alters serum-free choline and phospholipid-bound choline concentrations, and choline administration attenuates endotoxin-induced organ injury in dogs. Shock 2005;24: 288- 93.
20. Holmes-McNary MQ, Baldwin AS Jr, Zeisel SH. Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor kappaB. J Biol Chem 2001;276: 41197-204.
21. Kolahian S, Gosens R. Cholinergic regulation of airway inflammation and remodelling. J Allergy (Cairo) 2012;2012: 681258.
22. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007;117: 289-96.
23. de Jonge WJ, Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007;151: 915-29.
24. Blanchet MR, Israel-Assayag E, Cormier Y. Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist. Eur Respir J 2005;26: 21-7.
25. Cansev M, Ilcol YO, Yilmaz MS, Hamurtekin E, Ulus IH. Choline, CDPcholine or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system. Eur J Pharmacol 2008;589: 315-22.
26. Savani RC, Godinez RI, Godinez MH, et al. Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C. Am J Physiol Lung Cell Mol Physiol 2001;281: L685-96.
27. Ballard PL, Gonzales LW, Godinez RI, et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res 2006;59: 157-62.
28. Katz LA, Klein JM. Repeat surfactant therapy for postsurfactant slump. J Perinatol 2006;26: 414-22.
29. Cogo PE, Zimmermann LJ, Pesavento R, et al. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Crit Care Med 2003;31: 1532-8.
30. Cogo PE, Toffolo GM, Gucciardi A, Benetazzo A, Cobelli C, Carnielli VP. Surfactant disaturated phosphatidylcholine kinetics in infants with bronchopulmonary dysplasia measured with stable isotopes and a twocompartment model. J Appl Physiol 2005;99: 323-9.
31. Ozdulger A, Cinel I, Koksel O, et al. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 2003;19: 366-72.
32. Askenazi SS, Perlman M. Pulmonary hypoplasia: lung weight and radial alveolar count as criteria of diagnosis. Arch Dis Child 1979;54: 614-8.
33. Bouadma L, Schortgen F, Ricard JD, Martet G, Dreyfuss D, Saumon G. Ventilation strategy affects cytokine release after mesenteric ischemiareperfusion in rats. Crit Care Med 2004;32: 1563-9.
34. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226: 497- 509.
35. Svanborg A, Svennerholm L. Plasma total lipids, cholesterol, triglycerides, phospholipids and free fatty acids in a healthy Scandinavian population. Acta Med Scand 1961;169: 43-9.
36. Mason RJ, Nellenbogen J, Clements JA. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976;17: 281-4.
37. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34: 497-500.
38. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70: 158-69.
39. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 1990;186: 421-31.
40. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 1982;70: 598-607.